Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Long-Term Investments (2020 - 2021)

Insight Molecular Diagnostics' Long-Term Investments history spans 1 years, with the latest figure at $13.4 million for Q4 2020.

  • For Q4 2020, Long-Term Investments changed N/A year-over-year to $13.4 million; the TTM value through Dec 2020 reached $13.4 million, changed N/A, while the annual FY2020 figure was $13.4 million, N/A changed from the prior year.
  • Long-Term Investments for Q4 2020 was $13.4 million at Insight Molecular Diagnostics, down from $13.9 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $13.9 million in Q3 2020 and bottomed at $13.4 million in Q4 2020.